These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2943871)

  • 21. Comparison of soluble dopamine D2-receptors from three species.
    Madras BK; Davis A; Seeman P
    Eur J Pharmacol; 1982 Mar; 78(4):431-8. PubMed ID: 7075677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimal conditions for [3H]apomorphine binding and anomalous equilibrium binding of [3H]apomorphine and [3H]spiperone to rat striatal membranes: involvement of surface phenomena versus multiple binding sites.
    Leysen JE; Gommeren W
    J Neurochem; 1981 Jan; 36(1):201-19. PubMed ID: 7463046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Solubilisation of high-affinity dopamine receptors.
    Gorissen H; Laduron P
    Nature; 1979 May; 279(5708):72-4. PubMed ID: 450076
    [No Abstract]   [Full Text] [Related]  

  • 24. Correspondency between different affinity states and target size of the bovine striatal D2 dopamine receptor.
    Kuno T; Tanaka C
    Biochem Biophys Res Commun; 1983 Nov; 117(1):65-70. PubMed ID: 6197972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine D2 receptor binding in adrenal medulla: characterization using [3H]spiperone.
    Quik M; Bergeron L; Mount H; Philie J
    Biochem Pharmacol; 1987 Nov; 36(21):3707-13. PubMed ID: 2960326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-linked oligosaccharides are responsible for rat striatal dopamine D2 receptor heterogeneity.
    Clagett-Dame M; McKelvy JF
    Arch Biochem Biophys; 1989 Oct; 274(1):145-54. PubMed ID: 2528326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
    Urwyler S; Markstein R
    J Neurochem; 1986 Apr; 46(4):1058-67. PubMed ID: 2936868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo [3H]spiperone binding: evidence for accumulation in corpus striatum by agonist-mediated receptor internalization.
    Chugani DC; Ackermann RF; Phelps ME
    J Cereb Blood Flow Metab; 1988 Jun; 8(3):291-303. PubMed ID: 2966803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ontogeny of dopaminergic function in the rat midbrain tegmentum, corpus striatum and frontal cortex.
    Noisin EL; Thomas WE
    Brain Res; 1988 Jun; 469(1-2):241-52. PubMed ID: 3401800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Purification of brain D2 dopamine receptor.
    Williamson RA; Worrall S; Chazot PL; Strange PG
    EMBO J; 1988 Dec; 7(13):4129-33. PubMed ID: 3243275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine D2 receptors in the anterior pituitary: a single population without reciprocal antagonist/agonist states.
    George SR; Watanabe M; Seeman P
    J Neurochem; 1985 Apr; 44(4):1168-77. PubMed ID: 2579204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of heavy metal cations, sulfhydryl reagents and other chemical agents on striatal D2 dopamine receptors.
    Scheuhammer AM; Cherian MG
    Biochem Pharmacol; 1985 Oct; 34(19):3405-13. PubMed ID: 3931643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reconstitution of affinity-purified dopamine D2 receptor binding activities by specific lipids.
    Srivastava LK; Kazmi SM; Blume AJ; Mishra RK
    Biochim Biophys Acta; 1987 Jun; 900(2):175-82. PubMed ID: 2954584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Solubilization and characterization of striatal dopamine receptors.
    Lew JY; Goldstein M
    J Neurochem; 1984 May; 42(5):1298-305. PubMed ID: 6707634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An anti-peptide antibody that recognizes the dopamine D2 receptor from bovine striatum.
    Plug MJ; Dijk J; Maassen JA; Möller W
    Eur J Biochem; 1992 May; 206(1):123-30. PubMed ID: 1350246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycoprotein nature of D2 dopamine receptors.
    Grigoriadis DE; Niznik HB; Jarvie KR; Seeman P
    FEBS Lett; 1988 Jan; 227(2):220-4. PubMed ID: 2962888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the binding of [3H]spiperone and [3H]domperidone in homogenates of mammalian retina and caudate nucleus.
    Watling KJ; Iversen LL
    J Neurochem; 1981 Nov; 37(5):1130-43. PubMed ID: 7299392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
    Hancock AA; Marsh CL
    Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of the bovine striatal D2 receptor, but not the D1 receptor, in bovine adrenal medulla.
    Maroto R; López MG; del Valle M; Naranjo JR; Mellström B; García AG
    Mol Pharmacol; 1995 Jan; 47(1):40-50. PubMed ID: 7838132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Purification of bovine striatal dopamine D-2 receptor by affinity chromatography.
    Ramwani J; Mishra RK
    J Biol Chem; 1986 Jul; 261(19):8894-8. PubMed ID: 2941422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.